Moreover, we further characterized the roles of WDR76 in HFD-induced obesity and hepatic steatosis, suggesting WDR76 as a potential target for the treatment of obesity and metabolic diseases related to HFD. This evidence concerns the gene WDR76 and Other metabolic disease.